Funding
Socially responsible licensing To bring an academic invention to market, a company usually must acquire a license to develop it, a process that often presents challenges. Socially Responsible Licensing (SRL) addresses these challenges by encouraging broad access to products for the benefit of society by ensuring that market inefficiencies are overcome and global access is prioritized. This licensing process often causes challenges, like difficulties in contract negotiations. Subsidies The Subsidies category focuses on government and institutional financial aid available to support the development of new therapies. This includes information on various subsidy programs, eligibility criteria, application processes, and deadlines. The goal is to help researchers, pharmaceutical companies, and healthcare institutions access public funds that can significantly reduce the financial burden of research and development. Private investments The private investments category centers on the role of private investors in funding and accelerating the development of new therapies. This includes information on venture capital firms, investment trends, and how to attract and secure private investments. The goal is to help startups and emerging companies understand the private investments landscape, prepare compelling pitches, and build relationships with investors. This category also covers the benefits and challenges of private investments, providing guidance on leveraging these investments to scale operations, drive innovation, and bring new therapies to market efficiently.
